All In Biotech

Drug Trial Radar · NCT04302116

Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm

Efficacy of Vigabatrin With High Dose Prednisolone Combination Therapy Versus Vigabatrin Alone for Infantile Spasm: a Randomized Trial

Last checked: Nov 19, 2026Latest source record: Aug 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 250 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

May 18, 2020

Primary completion

Jun 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Kullasate SakpichaisakulGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Mar 10, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 2 months, up to 14 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Infantile spasms (IS) are seizures associated with a severe infantile epileptic encephalopathy. Both cessation of spasms and electrographic response are necessary for the best neurodevelopmental outcomes. Adrenocorticotrophic hormone (ACTH), or prednisolone, or vigabatrin are considered the first-line treatment individually. However, ACTH expense and availability are the barriers in developing countries including Thailand. Vigabatrin, therefore, is the first recommended by Epilepsy Society of Thailand due to ACTH unavailability. Recently, combined steroid treatments (either ACTH or high dose prednisolone) with vigabatrin are superior in cessation of spasms compared to steroid treatment alone. Thus, this study is aimed to compare the efficacy of vigabatrin with high dose prednisolone combination therapy and vigabatrin alone.

Conditions

  • Infantile Spasm
  • West Syndrome

Interventions

  • Combination therapy with vigabatrin and prednisoloneDrug

    High dose prednisolone (40 - 60 mg/day) for 1 month combined with vigabatrin treatment (50-150 mg/kg/day) twice daily for 4 months

  • Vigabatrin TabletsDrug

    Vigabatrin (50-150 mg/kg/day) twice daily for 4 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cessation of spasmsTime frame: Assessed during Day 14 to Day 42 after treatment.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Queen Sirikit National Institute of Child Health

    Ratchathewi, Bangkok, Thailand · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.